Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 125 results found. Search for [ Abbreviated New Drug Applications ]

Results 1 to 21 of 125
PTI
January 23, 2021
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Liothyronine Sodium tablets USP, 5 mcg, 25 mcg, and 50 mcg, Cadila Healthcare said in a regulatory filing


BusinessToday.In
December 4, 2020
India Stock Market Highlights Today: During the session, Sensex touched a lifetime high of 45,148 and Nifty hit an all-time high of 13,280


BusinessToday.In
November 17, 2020
Pfizer filed a possible patent infringement petition against both companies in the United States District Court for the District of Delaware and two counts last week


PTI
July 18, 2020
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Butalbital, Acetaminophen and Caffeine tabletsin strengths of 50mg/325mg/40 mg, Zydus Cadila said in a statement


PTI
July 6, 2020
\"Having said so, we believe FY2021 will have more uncertainties than ever before. Consequently, our overall performance may be quite volatile,\" Dr Reddy's Laboratories said


PTI
June 19, 2020
Glenmark's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications pending approval with the USFDA


BusinessToday.In
June 4, 2020
Aurobindo Pharma share price opened with a gain of 3.91% today and later touched an all-time high of Rs 791, rising 5.38% on BSE against the last closing value of Rs 750.65


BusinessToday.In
New Delhi, June 3, 2020
In the fourth quarter ended March FY20, Aurobindo Pharma's revenue from operations was recorded at Rs 6,158.4 crore


Satish Reddy
February 28, 2020
The Indian pharmaceutical industry has taken robust strides in ensuring the highest possible standards in quality and efficacy of medicines at affordable costs to patients


PTI
November 26, 2019
Glenmark's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications pending approval with the USFDA


E Kumar Sharma
New Delhi, November 25, 2019
A number of biologics with huge markets are going off-patent in the US. Do Indian pharmaceutical companies have it in them to play this high-cost, high-risk game of launching biosimilars?


PB Jayakumar
New Delhi, November 8, 2019
Sun Pharma Q2 results: The drugmaker, which earns 37 per cent of its business from the US market, earned Rs 2,389.77 crore from the sale of formulations in the US in Q2FY20 against Rs 2397 crore in the corresponding quarter of the previous year


PTI
August 9, 2019
Drug firm Cadila Healthcare on Friday reported a consolidated net profit of Rs 303.6 crore for the quarter ended June 30, 2019.


PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


PTI
June 5, 2019



PTI
May 29, 2019



PTI
May 26, 2019



PTI
May 23, 2019



PTI
May 13, 2019



PTI
April 30, 2019



PAGES 1 OF 7  12345